Clinical Trial Detail

NCT ID NCT01526473
Title A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors H. Kim Lyerly

gastric adenocarcinoma

Advanced Solid Tumor

Her2-receptor positive breast cancer

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma



Age Groups: adult

Additional content available in CKB BOOST